Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,001,484
  • Shares Outstanding, K 55,638
  • Annual Sales, $ 248,170 K
  • Annual Income, $ 23,340 K
  • 60-Month Beta 0.51
  • Price/Sales 4.07
  • Price/Cash Flow 37.63
  • Price/Book 2.10
Trade VNDA with:

Options Overview Details

View History
  • Implied Volatility 60.60%
  • Historical Volatility 20.52%
  • IV Percentile 39%
  • IV Rank 20.11%
  • IV High 165.79% on 11/04/20
  • IV Low 34.12% on 08/11/21
  • Put/Call Vol Ratio 0.99
  • Today's Volume 209
  • Volume Avg (30-Day) 162
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 530
  • Open Int (30-Day) 470

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.20
  • Number of Estimates 1
  • High Estimate 0.20
  • Low Estimate 0.20
  • Prior Year 0.11
  • Growth Rate Est. (year over year) +81.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.51 +7.93%
on 09/29/21
18.82 -5.31%
on 10/15/21
+0.24 (+1.37%)
since 09/27/21
3-Month
15.13 +17.74%
on 08/20/21
19.85 -10.23%
on 07/29/21
-1.48 (-7.67%)
since 07/27/21
52-Week
10.07 +76.96%
on 10/28/20
21.86 -18.49%
on 07/01/21
+7.23 (+68.27%)
since 10/27/20

Most Recent Stories

More News
Vanda Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 3, 2021

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2021 on Wednesday, November 3,...

VNDA : 17.82 (-1.00%)
3 Promising Biotech Stocks to Buy Right Now

In addition to playing a crucial role in the fight against COVID-19, the biotech industry is focusing increasingly on developing solutions to treat other critical ailments. And given the industry’s solid...

QGEN : 53.44 (-2.73%)
EXEL : 21.30 (-1.66%)
VNDA : 17.82 (-1.00%)
Vanda Pharmaceuticals (VNDA) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Vanda (VNDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VNDA : 17.82 (-1.00%)
Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October...

VNDA : 17.82 (-1.00%)
Halliburton and DaVita rise while Cal-Maine and Lennox fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday:

VNDA : 17.82 (-1.00%)
CIR : 29.68 (-3.79%)
EXPR : 3.79 (-3.81%)
CADE : 20.31 (-1.65%)
CALM : 36.14 (+0.31%)
LII : 296.99 (-1.90%)
HAL : 25.12 (-3.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics...

See More

Key Turning Points

3rd Resistance Point 18.35
2nd Resistance Point 18.21
1st Resistance Point 18.01
Last Price 17.82
1st Support Level 17.67
2nd Support Level 17.53
3rd Support Level 17.33

See More

52-Week High 21.86
Last Price 17.82
Fibonacci 61.8% 17.36
Fibonacci 50% 15.97
Fibonacci 38.2% 14.57
52-Week Low 10.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar